Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Status:
Completed

Trial end date:
2008-10-01

Target enrollment:

Participant gender:

To measure lanthanum concentrations in bone in patients with hyperphosphatemia receiving dialysis

Phase 2

Bayer